We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $3.25B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
AUM
$821M
AUM Growth
-$89.7M
Cap. Flow
-$32.4M
Cap. Flow %
-3.95%
Top 10 Hldgs %
37.68%
Holding
413
New
15
Increased
113
Reduced
149
Closed
63

Sector Composition

Rank Sector Weight
1 Healthcare 23.71%
2 Technology 16.8%
3 Industrials 8.32%
4 Financials 7.1%
5 Consumer Discretionary 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLF icon
101
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$1.4M 0.17%
36,510
-3,197
-8% -$126K
DE icon
102
Deere & Co
DE
$168B
$1.31M 0.16%
3,599
-374
-9% -$130K
RSP icon
103
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$1.29M 0.16%
8,432
+399
+5% +$63K
CHRW icon
104
C.H. Robinson
CHRW
$17.5B
$1.28M 0.16%
12,214
+662
+6% +$64.3K
MKC icon
105
McCormick & Company Non-Voting
MKC
$14.2B
$1.28M 0.16%
13,396
+759
+6% +$64.6K
BALL icon
106
Ball Corp
BALL
$16.8B
$1.28M 0.16%
14,496
+580
+4% +$53.6K
MTZ icon
107
MasTec
MTZ
$21.9B
$1.28M 0.16%
14,393
+528
+4% +$48.3K
ACGL icon
108
Arch Capital
ACGL
$33.6B
$1.27M 0.15%
28,029
+989
+4% +$42K
ALLE icon
109
Allegion
ALLE
$14.4B
$1.25M 0.15%
10,309
+297
+3% +$38.9K
ALGN icon
110
Align Technology
ALGN
$12.3B
$1.24M 0.15%
2,674
+71
+3% +$45.6K
MRK icon
111
Merck
MRK
$318B
$1.23M 0.15%
15,363
-1,039
-6% -$82.8K
EXP icon
112
Eagle Materials
EXP
$6.57B
$1.21M 0.15%
8,328
+445
+6% +$68.4K
MS icon
113
Morgan Stanley
MS
$340B
$1.14M 0.14%
11,512
+224
+2% +$22.3K
BSV icon
114
Vanguard Short-Term Bond ETF
BSV
$44.6B
$1.13M 0.14%
14,063
-31,915
-69% -$2.6M
ARES icon
115
Ares Management
ARES
$30.9B
$1.12M 0.14%
15,402
+1,128
+8% +$91.8K
VO icon
116
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$1.11M 0.14%
19,444
-224
-1% -$14K
VRSK icon
117
Verisk Analytics
VRSK
$25B
$1.1M 0.13%
5,588
+218
+4% +$47.6K
HOLX
118
DELISTED
Hologic
HOLX
$1.07M 0.13%
15,145
+706
+5% +$51.9K
VWO icon
119
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$1.06M 0.13%
21,340
-2,614
-11% -$132K
DHR icon
120
Danaher
DHR
$144B
$1.05M 0.13%
4,242
-457
-10% -$126K
SNA icon
121
Snap-on
SNA
$21.5B
$1.05M 0.13%
5,123
+53
+1% +$11.3K
GMED icon
122
Globus Medical
GMED
$11.2B
$1.04M 0.13%
15,349
+723
+5% +$52.5K
MRNA icon
123
Moderna
MRNA
$23.6B
$1.03M 0.13%
6,469
-2,310
-26% -$675K
CTAS icon
124
Cintas
CTAS
$81.3B
$1.03M 0.13%
10,844
+116
+1% +$12.5K
DFAX icon
125
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.4B
$1.03M 0.13%
39,981

Similar funds

Pallas Capital Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Pallas Capital Advisors held 413 positions worth $821M, down 9.9% from $911M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pallas Capital Advisors withdrew a net $32.4M in Q4 2021, closing 63 positions and reducing 149 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $2.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Pallas Capital Advisors opened a new position in Janus International worth $21.8M.

  • Pallas Capital Advisors's largest Q4 2021 buy was Janus International: 2,172,601 shares worth $21.8M.
  • Pallas Capital Advisors added most to iShares 0-5 Year TIPS Bond ETF in Q4 2021, an estimated $2.61M increase.
  • Pallas Capital Advisors's biggest Q4 2021 reduction was Intuitive Surgical, cutting an estimated $12M.
  • Pallas Capital Advisors fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2021, selling an estimated $2.44M.
  • Pallas Capital Advisors's ten largest holdings make up 38% of its $821M portfolio in Q4 2021.
  • Pallas Capital Advisors opened 15 new positions and closed 63 in Q4 2021.
  • Pallas Capital Advisors's portfolio value fell 9.9% quarter-over-quarter to $821M.

Based on Pallas Capital Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.